Economic impact of cardiac resynchronization therapy in heart failure patients. Available evidence and evaluation of the CRT-Eucomed model for cost-effectiveness analysis;L'impatto economico della terapia di resincronizzazione in pazienti con scompenso cardiaco. Evidenze disponibili e valutazione del modello CRT-Eucomed per l'analisi del rapporto costo-efficacia

Italian Heart Journal Supplement

Volumn 6, Issue 12, 2005, Pages 796-803

  Fattore, Giovanni ^a,b   Landolina, Maurizio ^c   Bontempi, Luca ^d   Cacciatore, Giuseppe ^e   Curnis, Antonio ^d   Gulizia, Michele ^f   Padeletti, Luigi ^g   Mazzei, Luigi ^h   Tavazzi, Luigi ^c  

^a Università Degli Studi Parthenope   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d SPEDALI CIVILI   (Italy)

^e SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^f Ospedale San Luigi San Currò   (Italy)

^g UNIVERSITY OF FLORENCE   (Italy)

^h Assobiomedica   (Italy)

Author keywords

Cardiac; Heart failure; Resynchronization therapy

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; ITALY; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; COMPUTER PROGRAM; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; EUROPE; HEART PACING; METHODOLOGY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

CARDIAC PACING, ARTIFICIAL; COST-BENEFIT ANALYSIS; EUROPE; HEART FAILURE, CONGESTIVE; HUMANS; ITALY; MODELS, ECONOMIC; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS; SOFTWARE;

EID: 33645036959     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. McKee PA, Castelli PW, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-6.
2. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997; 18: 208-25.
3. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993; 14: 1158-62.
4. Cleland JG, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail 1999; 1: 229-41.
5. McAlister FA, Teo KK, Taher M, et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J 1999; 138: 87-94.
6. Cowie MR, Wood DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000; 83: 505-10.
7. Ministero della Salute. Clinical evidence: una sintesi delle migliori prove di efficacia. Milano: Zadig Editore, 2001.
8. Schweiger C, Maggioni AP. Scompenso cardiaco ancora in attesa di strategie. Sole 24 Ore Sanità, 20-26 novembre 2001.
9. Ministero della Salute. Rapporto schede di dimissione o-spedaliera (SDO) 2002. www.ministerosalute.it
10. Hare JM. Cardiac resynchronization therapy for heart failure. N Engl J Med 2002; 346: 1902-5.
11. Abraham WT, Fisher WG, Smith AL, et al, for the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-53.
12. Auricchio A, Stellbrink C, Sack S, et al, for the Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002; 29: 2026-33.
13. Braunschweig F, Linde C, Gadler F, Rydén L. Reduction of hospital days by biventricular pacing. Eur J Heart Fail 2000; 2: 399-406.
14. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 2002; 40: 111-8.
15. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomized controlled trials. JAMA 2003; 289: 730-40.
16. Bristow MR, Saxon LA, Boehmer J, et al, for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.
17. McAlister FA, Ezekowitz JA, Wiebe N, et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004; 141: 381-90.
18. Cleland GF, Daubert JC, Erdmann E, Gras D, Kappenberger L, Tavazzi L, for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.
19. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002; 23: 1780-7.
20. Cazeau S, Leclercq C, Lavergne T, et al, for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-80.
21. Young JB, Abraham WT, Smith AL, et al, for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE-ICD Trial. JAMA 2003; 289: 2685-94.
22. Higgins SL, Hummed JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42: 1454-9.
23. Curnis A, Caprari F, Mascioli G, et al. Valutazione economica della resincronizzazione cardiaca nei pazienti affetti da scompenso cardiaco moderato-avanzato. Risultati dello studio BRESCIA. Pharmacoeconomics Italian Research Articles 2003; 5: 11-22.
24. Dixon LJ, Murtagh JG, Richardson SG, Chew EW. Reduction in hospitalization rates following cardiac resynchronization therapy in cardiac failure: experience from a single centre. Europace 2004; 6: 586-9.
25. Bocchiardo M, Martelli E, Achilli A, et al. Valutazione economica della terapia di resincronizzazione cardiaca: un'analisi su 98 pazienti in Italia. (abstr) Ital Heart J 2004; 5 (Suppl 5): 57S.
26. Banz K. Cardiac resynchronization therapy (CRT) in heart failure. A model to assess the economic value of this new medical technology. Value Health 2005; 8: 128-39.
27. Nichol G, Kaul P, Hustzi E, Bridges JF. Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure. Ann Intern Med 2004; 141: 343-51.
28. Ricci R, Ansalone G, Toscano S, et al. Cardiac resynchronization: materials, technique and results. The InSync Italian Registry. Eur Heart J 2000; 2 (Suppl J): J6-J15.
29. Lewis EF, Johnson PA, Johnson W, Collins C, Griflin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001; 20: 1016-24.
30. Auricchio A, Abraham WT. Cardiac resynchronization therapy: current state of the art. Cost versus benefit. Circulation 2004; 109: 300-7.
31. Tavazzi L. Ventricular pacing: a promising new therapeutic strategy in heart failure. For whom? Eur Heart J 2000; 21: 1246-50.